John an entrepreneur and family man with a track record in business development and depth of expertise in this new venture.

Dr. Kudzai has a PhD in agricultural microbiology and is a leading consultant in the regulated cannabis industry, ensuring compliance and quality assurance in line with both international GMP and GAP standards.

David is a qualified attorney of the South African High Court, with extensive knowledge in compliance, commercial and general litigation. David brings his expertise to the team assisting with all risk assessment.

Mark has a bachelor’s degree in psychology. He has worked in the IT industry in various roles for- American Express, PPC Cement, Dimension Data. He has a fascination with the healthcare industry and economy, and he reads and absorbs ongoing research

Trading in cannabis at a medical standard must be in compliance with Good Manufacturing Practices (GMP) and Good Agricultural Processes (GAP). The lack of smart contracts in the industry causes inefficiencies, increasing risks of errors, delays, and compliance issues.

Without automated systems and smart contracts, businesses face higher risks of human error, delays, and compliance violations, as well as suffering from a lack of tracking and transparency making it harder to ensure trust and streamline operations, from seed to sale.

The cannabis industry is vulnerable to counterfeit products, which can harm consumers and damage brand reputations. There is a substantial gap in the market for a blockchain-enabled solution covering both hardware and software.

Systems remain largely paper-based leaving manufacturers vulnerable to inefficiencies, regulatory risks, data breaches and potentially increased costs. Companies struggle to optimise operations, ensure compliance, and protect sensitive information, ultimately hindering growth in this rapidly expanding sector.

Cannabis businesses often operate in multiple jurisdictions with different regulations, making it difficult to maintain consistent compliance and operations.

The cannabis industry faces operational and financial challenges, including fragmented supply chains, introduction of foreign materials, brand protection, complex regulations, and under-specified product, all of which hinder growth and efficiency.

The lack of real-time insights and advanced analytics leads to inefficiencies in operations, missed growth opportunities, and difficulties in predicting market trends. Businesses struggle to optimise supply chains, understand customer behaviour, and make informed strategic decisions.

Limited labelling and restricted access to genetic information, leads to inconsistent product quality, reduced consumer trust, and challenges in verifying strain origins and medicinal properties.

The cannabis industries lack of proof of providence makes it hard to verify product origin, authenticity, and quality, leading to concerns over counterfeit goods and market inconsistencies.